Fragile X Mental Retardation Protein: Nucleocytoplasmic Shuttling and Association with Somatodendritic Ribosomes
暂无分享,去创建一个
S. Hersch | S. Warren | C. Gutekunst | Yue Feng | D. Eberhart | Hong Yi
[1] S. Warren,et al. The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. , 1996, Human molecular genetics.
[2] G. Dreyfuss,et al. Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them , 1996, Molecular and cellular biology.
[3] M. Olink-Coux,et al. Localization and active transport of mRNA in axons of sympathetic neurons in culture , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[4] É. Khandjian,et al. The fragile X mental retardation protein is associated with ribosomes , 1996, Nature Genetics.
[5] A. Poustka,et al. Highly conserved 3' UTR and expression pattern of FXR1 points to a divergent gene regulation of FXR1 and FMR1. , 1995, Human molecular genetics.
[6] É. Khandjian,et al. Prevalence of carriers of premutation-size alleles of the FMRI gene--and implications for the population genetics of the fragile X syndrome. , 1995, American journal of human genetics.
[7] R. Nussbaum,et al. The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. , 1995, The EMBO journal.
[8] D. Nelson,et al. Intragenic loss of function mutations demonstrate the primary role of FMR1 in fragile X syndrome , 1995, Nature Genetics.
[9] R. Nussbaum,et al. FXR1, an autosomal homolog of the fragile X mental retardation gene. , 1995, The EMBO journal.
[10] J. Morris,et al. Differential subcellular mRNA targeting: deletion of a single nucleotide prevents the transport to axons but not to dendrites of rat hypothalamic magnocellular neurons. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[11] S. Warren,et al. Translational suppression by trinucleotide repeat expansion at FMR1 , 1995, Science.
[12] C. Gravholt,et al. Quantitative comparison of FMR1 gene expression in normal and premutation alleles. , 1995 .
[13] A. Chakravarti,et al. Down syndrome consequent to a cryptic maternal 12p;21q chromosome translocation. , 1995, American journal of medical genetics.
[14] M. Gassmann,et al. Tissue-specific expression of a FMR1/β-galactosidase fusion gene in transgenic mice , 1995 .
[15] Rosalind,et al. Two new cases of FMR1 deletion associated with mental impairment. , 1995, American journal of human genetics.
[16] S. Warren,et al. Quantitative comparison of FMR1 gene expression in normal and premutation alleles. , 1995, American journal of human genetics.
[17] S. Warren,et al. Triplet repeat expansion mutations: the example of fragile X syndrome. , 1995, Annual review of neuroscience.
[18] J. Eberwine,et al. On the nature and differential distribution of mRNAs in hippocampal neurites: implications for neuronal functioning. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[19] O. Steward,et al. Dendrites as compartments for macromolecular synthesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[20] C. Burd,et al. Conserved structures and diversity of functions of RNA-binding proteins. , 1994, Science.
[21] Guy Nagels,et al. Fmr1 knockout mice: A model to study fragile X mental retardation , 1994, Cell.
[22] S. Warren,et al. Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles , 1994, Cell.
[23] R. Nussbaum,et al. Essential role for KH domains in RNA binding: Impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome , 1994, Cell.
[24] B. Oostra,et al. A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome. , 1994, Human molecular genetics.
[25] M. Morales,et al. Aggregation of vasopressin mRNA in a subset of axonal swellings of the median eminence and posterior pituitary: light and electron microscopic evidence , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[26] J. van Minnen. RNA in the axonal domain: a new dimension in neuronal functioning? , 1994, The Histochemical journal.
[27] W. Brown,et al. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. , 1994, JAMA.
[28] S. Warren,et al. FMR1 protein: conserved RNP family domains and selective RNA binding. , 1993, Science.
[29] John Calvin Reed,et al. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. , 1993, Cancer research.
[30] D. Nelson,et al. High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome. , 1993, Human molecular genetics.
[31] J. Brosius,et al. Transport of BC1 RNA in hypothalamo-neurohypophyseal axons , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[32] J. Mandel,et al. The FMR–1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation , 1993, Nature Genetics.
[33] I. Weiler,et al. Metabotropic glutamate receptors trigger postsynaptic protein synthesis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[34] R. Nussbaum,et al. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein , 1993, Cell.
[35] B. Oostra,et al. Characterization and localization of the FMR-1 gene product associated with fragile X syndrome , 1993, Nature.
[36] J. Mallet,et al. Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain , 1993, Nature Genetics.
[37] T. Bliss,et al. Changes in protein synthesis accompanying long-term potentiation in the dentate gyrus in vivo , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[38] David E. Housman,et al. Tissue specific expression of FMR–1 provides evidence for a functional role in fragile X syndrome , 1993, Nature Genetics.
[39] J. Sutcliffe,et al. DNA methylation represses FMR-1 transcription in fragile X syndrome. , 1992, Human molecular genetics.
[40] B. Neel,et al. The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence , 1992, Cell.
[41] J. Sutcliffe,et al. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox , 1991, Cell.
[42] W. Brown,et al. Analysis of neocortex in three males with the fragile X syndrome. , 1991, American journal of medical genetics.
[43] Ben A. Oostra,et al. Absence of expression of the FMR-1 gene in fragile X syndrome , 1991, Cell.
[44] J. Sutcliffe,et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome , 1991, Cell.
[45] J. Mandel,et al. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome , 1991, Science.
[46] J. Brosius,et al. Dendritic location of neural BC1 RNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[47] M. Krug,et al. Long-term potentiation induced changes in protein synthesis of hippocampal subfields of freely moving rats: time-course. , 1991, Biomedica biochimica acta.
[48] P. Sanna,et al. mRNA coding for oxytocin is present in axons of the hypothalamo-neurohypophysial tract. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[49] M. Waxham,et al. In situ hybridization histochemistry of Ca2+/calmodulin-dependent protein kinase in developing rat brain , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[50] I. Wool,et al. Antiribosomal S10 antibodies in humans and MRL/lpr mice with systemic lupus erythematosus. , 1989, Arthritis and rheumatism.
[51] N. Thompson,et al. Inhibition of in vivo and in vitro transcription by monoclonal antibodies prepared against wheat germ RNA polymerase II that react with the heptapeptide repeat of eukaryotic RNA polymerase II. , 1989, The Journal of biological chemistry.
[52] A. Matus,et al. Selective localization of messenger RNA for cytoskeletal protein MAP2 in dendrites , 1988, Nature.
[53] O. Steward,et al. Protein-synthetic machinery beneath postsynaptic sites on CNS neurons: association between polyribosomes and other organelles at the synaptic site , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[54] E. Castigli,et al. Occurrence and Sequence Complexity of Polyadenylated RNA in Squid Axoplasm , 1987, Journal of neurochemistry.
[55] T. Teyler,et al. Long-term potentiation. , 1987, Annual review of neuroscience.
[56] O. Steward,et al. Protein-synthetic machinery at postsynaptic sites during synaptogenesis: a quantitative study of the association between polyribosomes and developing synapses , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[57] S. Heffelfinger,et al. Antibodies to bovine liver branched-chain 2-oxo acid dehydrogenase cross-react with this enzyme complex from other tissues and species. , 1983, The Biochemical journal.
[58] P. Greengard,et al. Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation , 1983, The Journal of cell biology.
[59] O. Steward. Alterations in polyribosomes associated with dendritic spines during the reinnervation of the dentate gyrus of the adult rat , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[60] W. Levy,et al. Preferential localization of polyribosomes under the base of dendritic spines in granule cells of the dentate gyrus , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.